# Thalomid

**erythema nodosum leprosum**

[Criteria Document](https://mygainwell-my.sharepoint.com/:w:/g/personal/kaelyn_dobbins_gainwelltechnologies_com/EXFO2E1GKl9GkIznoXmYp_kBfgAhD8ipO0-sUn5uuoDrfg?e=VnHG46){:target="_blank" rel="noopener}

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong></th>
<th>Glutarimide Immunomodulatory Agent</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong></td>
<td>Thalomid (thalidomide)</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong></td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products</strong></p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name</td>
<td>Corresponding Code(s)</td>
<td>Type of Code (GCNSeqNo, HICL, NDC)</td>
</tr>
<tr class="even">
<td></td>
<td>THALOMID</td>
<td>040279</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>THALOMID</td>
<td>040296</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>THALOMID</td>
<td>051879</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>THALOMID</td>
<td>062444</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong> </th>
<th><strong>Question ID</strong> </th>
<th><strong>Default Next Question ID</strong> </th>
<th><strong>Question Type</strong> </th>
<th><strong>Question Text</strong> </th>
<th><strong>Choice Text</strong> </th>
<th><strong>Next Question ID</strong> </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1</td>
<td>1000</td>
<td></td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?</td>
<td>Y</td>
<td>1001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>2</td>
<td>1001</td>
<td> </td>
<td>Select </td>
<td><p>Are the patient and prescriber enrolled in the Risk Evaluation and Mitigation Strategy (REMS) program?</p>
<p>  </p></td>
<td>Y</td>
<td>END (Approve x 365 days)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>1235</td>
<td></td>
<td>Free Text</td>
<td>Please provide the rationale for the medication being requested. </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 365 Days

| **Last Approved** | 4/11/2023 |
| ----------------- | --------- |
| **Other**         |           |
